A Phase I Study of Reduced-Intensity Conditioning and Allogeneic Stem Cell Transplantation Followed by Dose Escalation of Targeted Consolidation Immunotherapy with Gemtuzumab Ozogamicin in Children and Adolescents with CD33 + Acute Myeloid Leukemia

Phase I ◽

Myeloid Leukemia ◽

Phase I Study ◽

Gemtuzumab Ozogamicin ◽

Reduced Intensity ◽

Reduced Intensity Conditioning and Allogeneic Stem Cell Transplantation Followed By Targeted Consolidation Immunotherapy with Gemtuzumab Ozogamicin in Children and Adolescents with CD33+ Acute Myeloid Leukemia

Biology of Blood and Marrow Transplantation ◽

10.1016/j.bbmt.2013.12.299 ◽

2014 ◽

Vol 20 (2) ◽

pp. S183

Author(s):

Stacey Zahler ◽

Sumith Roy ◽

Angela Ricci ◽

Erin Morris ◽

Lauren Harrison ◽

...

Keyword(s):

Acute Myeloid Leukemia ◽

Stem Cell ◽

Children And Adolescents ◽

Myeloid Leukemia ◽

Gemtuzumab Ozogamicin ◽

Reduced Intensity ◽

370: Fludarabine-busulphan reduced intensity conditioning (RIC) identical sibling allogeneic stem cell transplantation (allo-SCT) in high risk acute myeloid leukemia and myelodisplastic syndrome

Biology of Blood and Marrow Transplantation ◽

10.1016/j.bbmt.2006.12.375 ◽

2007 ◽

Vol 13 (2) ◽

pp. 134-135 ◽

Cited By ~ 1

Author(s):

D. Valcarcel ◽

R. Martino ◽

J. Martin ◽

C. Ferra ◽

A. Sampol ◽

...

Keyword(s):

Acute Myeloid Leukemia ◽

Stem Cell ◽

High Risk ◽

Cell Transplantation ◽

Myeloid Leukemia ◽

Reduced Intensity ◽

Cytoreductive treatment with clofarabine/ara-C combined with reduced-intensity conditioning and allogeneic stem cell transplantation in patients with high-risk, relapsed, or refractory acute myeloid leukemia and advanced myelodysplastic syndrome

European Journal Of Haematology ◽

10.1111/j.1600-0609.2011.01703.x ◽

2011 ◽

Vol 88 (1) ◽

pp. 52-60 ◽

Cited By ~ 39

Author(s):

Stefanie Buchholz ◽

Elke Dammann ◽

Michael Stadler ◽

Juergen Krauter ◽

Gernot Beutel ◽

...

Keyword(s):

Acute Myeloid Leukemia ◽

Stem Cell ◽

High Risk ◽

Myeloid Leukemia ◽

Cytoreductive Treatment ◽

Refractory Acute Myeloid Leukemia ◽

Reduced Intensity ◽

Cardiovascular outcomes in patients receiving myeloablative vs. reduced intensity conditioning prior to allogeneic hematopoietic stem cell transplantation for acute myeloid leukemia

Bone Marrow Transplantation ◽

10.1038/s41409-020-01021-y ◽

2020 ◽

Author(s):

Majd A. El-Harasis ◽

Mehrdad Hefazi ◽

Raghav Julakanti ◽

William J. Hogan ◽

Mark R. Litzow ◽

...

Keyword(s):

Acute Myeloid Leukemia ◽

Stem Cell ◽

Hematopoietic Stem Cell Transplantation ◽

Cell Transplantation ◽

Myeloid Leukemia ◽

Hematopoietic Stem ◽

Reduced Intensity ◽

A phase II trial of sequential treatment with cytoreductive therapy and reduced intensity conditioning allogeneic stem cell transplantation for relapsed/ refractory acute myeloid leukemia, high risk myelodysplasia, or other high risk myeloid malignancies

http://isrctn.org/> ◽

10.1186/isrctn32336114 ◽

2012 ◽

Author(s):

Jamie Cavenagh

Keyword(s):

Acute Myeloid Leukemia ◽

Stem Cell ◽

High Risk ◽

Myeloid Leukemia ◽

Phase Ii Trial ◽

Refractory Acute Myeloid Leukemia ◽

Reduced Intensity ◽

Efficacy of Allogeneic Stem Cell Transplantation for Children and Adolescents with Acute Myeloid Leukemia After Myeloablative and Reduced-intensity Conditioning

Oncopediatrics ◽

10.15690/onco.v2.i4.1466 ◽

2015 ◽

Vol 2 (4) ◽

pp. 396-403 ◽

Cited By ~ 3

Author(s):

S.N. Bondarenko ◽

◽

S.V. Razumova ◽

N.V. Stancheva ◽

E.V. Semenova ◽

...

Keyword(s):

Acute Myeloid Leukemia ◽

Stem Cell ◽

Children And Adolescents ◽

Cell Transplantation ◽

Myeloid Leukemia ◽

Reduced Intensity ◽

Reduced intensity conditioning prior to allogeneic stem cell transplantation in first complete remission is effective in patients with acute myeloid leukemia and an intermediate-risk karyotype

International Journal of Hematology ◽

10.1007/s12185-010-0515-y ◽

2010 ◽

Vol 91 (3) ◽

pp. 436-445 ◽

Cited By ~ 13

Author(s):

Philipp G. Hemmati ◽

Theis H. Terwey ◽

Gero Massenkeil ◽

Philipp le Coutre ◽

Lam G. Vuong ◽

...

Keyword(s):

Acute Myeloid Leukemia ◽

Stem Cell ◽

Complete Remission ◽

Myeloid Leukemia ◽

Intermediate Risk ◽

First Complete Remission ◽

Reduced Intensity ◽

Phase I study of azacitidine following donor lymphocyte infusion for relapsed acute myeloid leukemia post allogeneic stem cell transplantation

Leukemia Research ◽

10.1016/j.leukres.2016.07.010 ◽

2016 ◽

Vol 49 ◽

pp. 1-6 ◽

Cited By ~ 17

Author(s):

Armin Ghobadi ◽

Jaebok Choi ◽

Mark A. Fiala ◽

Theresa Fletcher ◽

Jingxia Liu ◽

...

Keyword(s):

Acute Myeloid Leukemia ◽

Stem Cell ◽

Phase I ◽

Myeloid Leukemia ◽

Phase I Study ◽

Donor Lymphocyte Infusion ◽

Relapsed Acute Myeloid Leukemia ◽

A Phase I Study of Targeted, Dose-Escalated Intravenous Busulfan in Combination With Etoposide as Myeloablative Therapy for Autologous Stem Cell Transplantation in Acute Myeloid Leukemia

Clinical Lymphoma Myeloma & Leukemia ◽

10.1016/j.clml.2015.02.016 ◽

2015 ◽

Vol 15 (6) ◽

pp. 377-383 ◽

Cited By ~ 2

Author(s):

Gabriel N. Mannis ◽

Charalambos Andreadis ◽

Aaron C. Logan ◽

Lloyd E. Damon ◽

Leslie Z. Benet ◽

...

Keyword(s):

Acute Myeloid Leukemia ◽

Stem Cell ◽

Phase I ◽

Cell Transplantation ◽

Autologous Stem Cell Transplantation ◽

Myeloid Leukemia ◽

Phase I Study ◽

New sequential treatment with chemotherapy and reduced-intensity conditioning for allogeneic stem-cell transplantation in very high-risk acute myeloid leukemia

American Journal of Hematology ◽

10.1002/ajh.22029 ◽

2011 ◽

Vol 86 (7) ◽

pp. 619-621 ◽

Cited By ~ 3

Author(s):

Thomas Cluzeau ◽

Muriel De Matteis ◽

Nicolas Mounier ◽

Lionel Mannone ◽

Nicole Gratecos ◽

...

Keyword(s):

Acute Myeloid Leukemia ◽

Stem Cell ◽

High Risk ◽

Myeloid Leukemia ◽

Very High ◽

Reduced Intensity ◽